TrialThe Journal of clinical endocrinology and metabolism2021

A Selective Androgen Receptor Modulator (OPK-88004) in Prostate Cancer Survivors: A Randomized Trial.

Karol M Pencina et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.